Announcements Trials

Browse Landscape

Phase

Status

Completed 6 Unknown 3 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 45 Endometrial Neoplasms 10 Triple Negative Breast Neoplasms 4 Ovarian Neoplasms 3 Neoplasms 3 Neoplasm Metastasis 3 Fallopian Tube Neoplasms 3 Progesterone Resistance 2 HR+/HER2- Breast Cancer 2 HR Positive HER2 Negative Advanced Breast Cancer 2 Endometrial Hyperplasia 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Intraductal, Noninfiltrating 2 Breast Neoplasms, Male 2 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Prostatic Neoplasms 1 Polycystic Ovary Syndrome 1 Peritoneal Neoplasms 1 Pathologic Complete Response 1 Obesity 1 Neoplasms by Site 1 Low-Grade Serous Ovarian Cancer 1 Low Grade Serous Ovarian Carcinoma 1 Low Grade Serous Ovarian Cancer 1 Locoregional Recurrence 1 Leiomyoma 1 Infertility, Female 1 Infertility 1

Interventions

Metformin 3 Tamoxifen 1 Tablets 1 Megestrol Acetate 1 Liraglutide 1 Letrozole 1 Fertility Preservation 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Infertility × Letrozole × Clear all

NCT03011684 2025-05-08

TALES

University of California, San Francisco

Phase 3 Recruiting

Breast Neoplasms, Infertility

Data powered by HemOnc (CC BY 4.0) Colophon ⚡